NCT03538210

Brief Summary

Obesity prevalence rapidly increased in the past decades in French population with multiple health consequences responsible for excess mortality. In the same period of time, the number of bariatric procedures have developed exponentially. Despite its great efficacy on weight loss but also on resolution of comorbidities, bariatric surgery is not without risks. Our hypothesis is that a better understanding of the physio-pathological consequences of obesity and bariatric surgery, notably on the gastrointestinal tract, may allow to improve the treatment of obesity and to find alternatives to bariatric surgery. The main objective of this cohort study is to systematize the collection and the conservation of biological samples (blood, stomach, liver, intestine, adipose tissue) obtained during bariatric surgery, in obese subjects undergoing surgery (including sleeve gastrectomy, Roux-en-Y gastric bypass, or revisional intervention for complication or weight regain) in the University Hospital group of Paris Nord Val de Seine (HYPNVS). The main projects that will build on this cohort will cover the physiopathology of obesity and its consequences, notably in the field of gastrointestinal tract including: modification of gastro-intestinal plasticity in severe obesity and after bariatric surgery and alterations of absorption of nutriments (lipids, proteins, carbohydrates) induced by obesity and bariatric surgery. The inclusion in this project of obese subjects before surgery, or lean or obese subjects after surgery will allow to distinguish the impact of weight loss and surgery on gastrointestinal remodeling. This cohort will also allow to characterize stomach and intestinal proteome in severe obesity and to precise the influence of tissue inflammation on metabolic disorders associated with obesity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
360

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 16, 2018

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

March 6, 2018

Completed
3 months until next milestone

First Posted

Study publicly available on registry

May 29, 2018

Completed
7.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 3, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 3, 2026

Completed
Last Updated

March 31, 2026

Status Verified

March 1, 2026

Enrollment Period

8 years

First QC Date

March 6, 2018

Last Update Submit

March 26, 2026

Conditions

Keywords

obesity, bariatric surgery, gastrointestinal functions, adipose tissu, steatohepatitis

Outcome Measures

Primary Outcomes (1)

  • number of biological samples collected

    liver stomach and intestin samples will be performed during surgery for usual care. Adiposes tissues and blood samples will be performed for reseach, on the surgical site

    during surgery

Secondary Outcomes (4)

  • modifications of gastro-intestinal plasticity induces by obesity and bariatric surgery

    samples collected during surgery

  • alterations of absroption and metabolism of nutriments induced by obesity and bariatric surgery

    samples collected during surgery

  • gastric and intestinal proteome

    samples collected during surgery

  • tissue inflammation and fibrosis

    samples collected during surgery

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

severe obese subjects operated for bariatric surgery or reoperated for complication

You may qualify if:

  • severe obese subject with BMI above35 kg/m2, age above 18 ans who accept to participate
  • candidate for bariatric surgery according to HAS criteria
  • who will undergo either sleeve gastrectomy or gastric bypass
  • or who undergoesa revisional surgery for a complication of bariatric surgery
  • or who undergoes arevisional sugery fir insufficient weight loss
  • covered by an health insurance

You may not qualify if:

  • psychiatric disease or undertanding disorder
  • alchool abuse or other addiction
  • organ failure (including liver, heart or kidney)
  • chronic life-threatening illness
  • inflamatory disease or immunosuppressive treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Lousi Mourier (HUPNVS)

Colombes, Île-de-France Region, 92700, France

Location

MeSH Terms

Conditions

Obesity, MorbidObesityFatty Liver

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsLiver DiseasesDigestive System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 6, 2018

First Posted

May 29, 2018

Study Start

February 16, 2018

Primary Completion

March 3, 2026

Study Completion

March 3, 2026

Last Updated

March 31, 2026

Record last verified: 2026-03

Locations